Skip to main content
Ir a la página de inicio de la Comisión Europea (se abrirá en una nueva ventana)
español es
CORDIS - Resultados de investigaciones de la UE
CORDIS

Fluorinated Lipid Nanoparticles for Gene Delivery and Diagnostics

Objetivo

The formulation of drug nanocarriers has attracted increasing attention over the last decades. In particular, the possibility to combine
therapeutic and imaging functionalities in a single nanoplatform (theranostic) has been widely explored to advance therapeutic
approaches and promote the transition from conventional medicine to personalized medicine.
Drug nanocarriers, holding the potential to produce a revolution in medicine, are lipid nanoparticles (LNPs) for gene delivery. They
have proven versatility and efficacy even though today it is still not possible to predict and control their cellular uptake and targeted
delivery. One of the main unmet challenges of LNP formulations is increasing their cellular uptake and gene release into the cytosol.
Currently, it is possible to follow the fate of LNPs after administration only with the addition of labels (e.g. fluorophore) or specific
ribonucleic acid (RNA) sequence encoding for fluorescent protein. This results in the lack of possibility to follow the fate of LNPs once
administered in vivo with a non-invasive imaging technique. Theranostic strategies to deliver RNA and simultaneous imaging of
target organs is an important unmet goal.
Recently, it has been demonstrated that fluorination of components in gene delivery vehicles strongly improved their cellular uptake
and, most importantly, their gene endosomal escape. The fluorination strategies investigated so far use either -CF3 groups or long
linear perfluoroalkyl chains, but a tailored design of the fluorinated group could also endow the nanocarrier with excellent imaging
functions. In this context, FluoNeeD strategy is to tailor fluorination of LNPs in order to: (i) improve their therapeutic efficacy by
enhancing LNP cellular uptake and promoting gene endosomal escape; (ii) render LNPs trackable in vivo by 19F-MRI and in vitro/ex vivo by Raman microscopy.

Ámbito científico (EuroSciVoc)

Palabras clave

Programa(s)

Tema(s)

Régimen de financiación

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

Ver todos los proyectos financiados en el marco de este régimen de financiación

Convocatoria de propuestas

(se abrirá en una nueva ventana) HORIZON-MSCA-2022-PF-01

Ver todos los proyectos financiados en el marco de esta convocatoria

Coordinador

POLITECNICO DI MILANO
Aportación neta de la UEn
€ 212 163,84
Dirección
PIAZZA LEONARDO DA VINCI 32
20133 Milano
Italia
Región
Nord-Ovest Lombardia Milano
Tipo de actividad
Higher or Secondary Education Establishments
Enlaces
Coste total
Sin datos

Socios (2)